GIVE MISS CALL ON :- +91 99774 99927

Tag Archives: 100% Accurate Nifty Options Tips

CAPITALSTARS INDIAN EQUITY MARKET WRAP UP – 11 DEC 2018

Closing Bell: Sensex ends 190 pts higher, Nifty around 10,550 despite Patel’s exit, setback for BJP. In what was anticipated to be a day of bloodbath on D-Street, a trend reversal in the last few hours of trade helped Indian shares close on a positive note. An abrupt resignation by RBI governor Urjjit Patel late

CAPITALSTARS – MCX COMMODITY MARKET NEWS & LEVELS – 11 DEC 2018

Gold prices hold steady as stronger dollar weighs. Gold prices held steady early on Tuesday, supported by hopes that the U.S. Federal Reserve could pause its rate hike cycle sooner than previously thought, but a stronger dollar amid Brexit worries weighed on the precious metal. British Prime Minister Theresa May on Monday postponed a parliamentary

CAPITALSTARS – MCX COMMODITY EVENING MARKET NEWS UPDATES – 07 DEC 2018

BULLION:- Gold prices edged higher on Friday and were on track for their best week in 15, as the dollar weakened on renewed speculation of an imminent pause in the U.S. Federal Reserve’s tightening cycle. Markets now await U.S. nonfarm payrolls data, expected at 0830 ET (1330 GMT), for clues about the health of the

CAPITALSTARS – भारत में खरीदारी के लिए बेहतर हैं ये स्‍टॉक: 07 DEC 2018

The NSE benchmark Nifty opened the session with a gap-down below its 200-day moving average and drifted lower as the day progressed to end near the day’s low. At the end, Nifty registered a significant loss of 1.69 per cent to close at 10,601. The price action formed a significant bearish candle with an opening

CAPITALSTARS- INDIAN EQUITY MARKET OUTLOOK – 07 DEC 2018

Nifty likely to open higher. Indian Indices: Trends on SGX Nifty indicate that the index will open 51 points (0.48 percent) higher in India. Nifty futures were trading around 10,675 on the Singaporean exchange. Global Market: • Asian markets: Asian markets are higher today as Japanese and Hong Kong shares show gains. The Nikkei 225

TOP CORPORATE NEWS- 06 DEC 2018

Aurobindo to face lawsuit in US for Irbesartan contamination As per news sources, a lawsuit has been filed in Federal Court of Florida against Aurobindo Pharma for the contamination of its Irbesartan APIs, used in the treatment of high blood pressure. The class action lawsuit also named US pharma company ScieGen Pharmaceuticals, distributor Westminster Pharmaceuticals

CapitalStars FORUM